GlaxoSmithKline's new boss streamlines drug research

LONDON (Reuters) - GlaxoSmithKline's new Chief Executive Emma Walmsley announced plans on Wednesday to streamline drug research in a bid to improve returns in the group's core pharmaceuticals business.